SMG vs. FLGT

Last updated Apr 2, 2026

Compare and contrast key facts about The Scotts Miracle-Gro Company (SMG) and Fulgent Genetics, Inc. (FLGT).

Performance

SMG vs. FLGT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Scotts Miracle-Gro Company (SMG) and Fulgent Genetics, Inc. (FLGT). The values are adjusted to include any dividend payments, if applicable.

SMG vs. FLGT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SMG The Scotts Miracle-Gro Company	5.56%	-8.01%	8.28%	36.92%	-68.81%	-18.03%	96.18%	77.05%	-41.00%	14.46%
FLGT Fulgent Genetics, Inc.	-37.42%	42.23%	-36.11%	-2.92%	-70.39%	93.07%	303.88%	306.94%	-27.63%	-62.14%

Fundamentals

Market Cap SMG : $3.53B FLGT : $505.97M
EPS SMG : $1.55 FLGT : -$1.97
PS Ratio SMG : 1.06 FLGT : 1.57
Total Revenue (TTM) SMG : $3.35B FLGT : $322.67M
Gross Profit (TTM) SMG : $1.04B FLGT : $130.88M
EBITDA (TTM) SMG : $447.10M FLGT : -$45.71M

Returns By Period

In the year-to-date period, SMG achieves a 5.56% return, which is significantly higher than FLGT's -37.42% return.

SMG

• 1D: 0.33%
• 1M: -13.31%
• YTD: 5.56%
• 6M: 6.84%
• 1Y: 16.38%
• 3Y*: -0.16%
• 5Y*: -21.80%
• 10Y*: 1.42%

FLGT

• 1D: 3.40%
• 1M: 15.77%
• YTD: -37.42%
• 6M: -30.04%
• 1Y: -5.03%
• 3Y*: -19.25%
• 5Y*: -30.37%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SMG vs. FLGT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMG

SMG Risk / Return Rank: 53
SMG Sharpe Ratio Rank: 56
SMG Sortino Ratio Rank: 50
SMG Omega Ratio Rank: 50
SMG Calmar Ratio Rank: 56
SMG Martin Ratio Rank: 54

FLGT

FLGT Risk / Return Rank: 38
FLGT Sharpe Ratio Rank: 36
FLGT Sortino Ratio Rank: 37
FLGT Omega Ratio Rank: 40
FLGT Calmar Ratio Rank: 39
FLGT Martin Ratio Rank: 38

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMG vs. FLGT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Scotts Miracle-Gro Company (SMG) and Fulgent Genetics, Inc. (FLGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SMG	FLGT	Difference
Sharpe ratio Return per unit of total volatility	0.43	-0.08	+0.51
Sortino ratio Return per unit of downside risk	0.85	0.33	+0.52
Omega ratio Gain probability vs. loss probability	1.11	1.06	+0.05
Calmar ratio Return relative to maximum drawdown	0.68	-0.05	+0.73
Martin ratio Return relative to average drawdown	1.31	-0.15	+1.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SMG vs. FLGT - Sharpe Ratio Comparison

The current SMG Sharpe Ratio is 0.43, which is higher than the FLGT Sharpe Ratio of -0.08. The chart below compares the historical Sharpe Ratios of SMG and FLGT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SMG	FLGT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.43	-0.08	+0.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.48	-0.59	+0.11
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.04	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.22	0.08	+0.13

Correlation

The correlation between SMG and FLGT is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SMG vs. FLGT - Dividend Comparison

SMG's dividend yield for the trailing twelve months is around 4.33%, while FLGT has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SMG The Scotts Miracle-Gro Company	4.33%	4.52%	3.98%	4.14%	5.43%	1.59%	3.72%	2.13%	3.51%	1.93%	2.03%	2.85%
FLGT Fulgent Genetics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

SMG vs. FLGT - Drawdown Comparison

The maximum SMG drawdown since its inception was -83.55%, smaller than the maximum FLGT drawdown of -92.50%. Use the drawdown chart below to compare losses from any high point for SMG and FLGT.

Drawdown Indicators

	SMG	FLGT	Difference
Max Drawdown Largest peak-to-trough decline	-83.55%	-92.50%	+8.95%
Max Drawdown (1Y) Largest decline over 1 year	-23.85%	-55.30%	+31.45%
Max Drawdown (5Y) Largest decline over 5 years	-83.55%	-87.56%	+4.01%
Max Drawdown (10Y) Largest decline over 10 years	-83.55%	—	—
Current Drawdown Current decline from peak	-71.06%	-91.06%	+20.00%
Average Drawdown Average peak-to-trough decline	-20.88%	-61.04%	+40.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.27%	18.34%	-6.07%

Volatility

SMG vs. FLGT - Volatility Comparison

The Scotts Miracle-Gro Company (SMG) has a higher volatility of 14.01% compared to Fulgent Genetics, Inc. (FLGT) at 10.83%. This indicates that SMG's price experiences larger fluctuations and is considered to be riskier than FLGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SMG	FLGT	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.01%	10.83%	+3.18%
Volatility (6M) Calculated over the trailing 6-month period	22.89%	56.45%	-33.56%
Volatility (1Y) Calculated over the trailing 1-year period	38.62%	59.71%	-21.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.95%	51.88%	-5.93%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.05%	76.12%	-36.07%

Financials

SMG vs. FLGT - Profitability Comparison

The chart below illustrates the profitability comparison between The Scotts Miracle-Gro Company and Fulgent Genetics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported a gross profit of 88.70M and revenue of 354.40M. Therefore, the gross margin over that period was 25.0%.

FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported a gross profit of 32.58M and revenue of 83.34M. Therefore, the gross margin over that period was 39.1%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported an operating income of -21.80M and revenue of 354.40M, resulting in an operating margin of -6.2%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported an operating income of -6.77M and revenue of 83.34M, resulting in an operating margin of -8.1%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported a net income of -125.00M and revenue of 354.40M, resulting in a net margin of -35.3%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported a net income of -23.42M and revenue of 83.34M, resulting in a net margin of -28.1%.